Literature DB >> 7495776

A case of amiodarone-associated pulmonary toxicity.

K H Kwon1, S W Jeong, S Uh, Y H Kim, S Y Jin, J S Park, C H Kang, C S Park.   

Abstract

Amiodarone is an iodinated benzofuran derivative that represents a new and extremely effective therapy for certain life-threatening refractory cardiac arrgythmia. There are numerous side effects associated with amiodarone therapy, including corneal microdeposits. Skin reactions and others. Pulmonary toxicity, however, represents the most serious adverse reaction limiting the clinical effecacy of this antidysrhythmic drug. Recently, we experienced a case of amiodarone-induced pulmonary toxicity confirmed by open lung biopsy with light-and electron-microscopy. So, we report a case of amiodarone-induced pulmonary toxicity with a literature review.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7495776      PMCID: PMC4532041          DOI: 10.3904/kjim.1995.10.2.155

Source DB:  PubMed          Journal:  Korean J Intern Med        ISSN: 1226-3303            Impact factor:   2.884


  13 in total

1.  CT demonstration of high attenuation pleural-parenchymal lesions due to amiodarone therapy.

Authors:  J E Kuhlman; J C Scatarige; E K Fishman; E A Zerhouni; S S Siegelman
Journal:  J Comput Assist Tomogr       Date:  1987 Jan-Feb       Impact factor: 1.826

2.  Amiodarone pulmonary toxicity: clinical and subclinical features.

Authors:  P C Adams; G J Gibson; A R Morley; A J Wright; P A Corris; D S Reid; R W Campbell
Journal:  Q J Med       Date:  1986-05

3.  Side effects and possible contraindications of amiodarone use.

Authors:  L Harris; W J McKenna; E Rowland; D M Krikler
Journal:  Am Heart J       Date:  1983-10       Impact factor: 4.749

4.  Relation of serum reverse T3 to amiodarone antiarrhythmic efficacy and toxicity.

Authors:  N Z Kerin; R D Blevins; D Benaderet; K Faitel; R Jarandilla; C Garfinkel; S Klein; M Rubenfire
Journal:  Am J Cardiol       Date:  1986-01-01       Impact factor: 2.778

5.  Amiodarone pulmonary toxicity. Clinical, radiologic, and pathologic correlations.

Authors:  J I Kennedy; J L Myers; V J Plumb; J D Fulmer
Journal:  Arch Intern Med       Date:  1987-01

Review 6.  Amiodarone pulmonary toxicity. Recognition and pathogenesis (Part I).

Authors:  W J Martin; E C Rosenow
Journal:  Chest       Date:  1988-05       Impact factor: 9.410

7.  Gallium scintigraphy in the detection of amiodarone lung toxicity.

Authors:  M Moinuddin; J Rockett
Journal:  AJR Am J Roentgenol       Date:  1986-09       Impact factor: 3.959

Review 8.  Amiodarone pulmonary toxicity.

Authors:  L Rakita; S M Sobol; N Mostow; T Vrobel
Journal:  Am Heart J       Date:  1983-10       Impact factor: 4.749

9.  Prospective evaluation of amiodarone pulmonary toxicity.

Authors:  P J Kudenchuk; D J Pierson; H L Greene; E L Graham; G K Sears; G B Trobaugh
Journal:  Chest       Date:  1984-10       Impact factor: 9.410

10.  Amiodarone pulmonary toxicity: early changes in pulmonary function tests during amiodarone rechallenge.

Authors:  E P Veltri; P R Reid
Journal:  J Am Coll Cardiol       Date:  1985-10       Impact factor: 24.094

View more
  1 in total

1.  The incidence and predictors of overall adverse effects caused by low dose amiodarone in real-world clinical practice.

Authors:  Hack-Lyoung Kim; Jae-Bin Seo; Woo-Young Chung; Sang-Hyun Kim; Myung-A Kim; Joo-Hee Zo
Journal:  Korean J Intern Med       Date:  2014-08-28       Impact factor: 2.884

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.